NCT02463617

Brief Summary

This study aims to characterize the nature of impulsivity in Parkinson's Disease (PD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 21, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 13, 2015

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 4, 2015

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

October 5, 2021

Status Verified

September 1, 2021

Enrollment Period

6.6 years

First QC Date

February 13, 2015

Last Update Submit

September 28, 2021

Conditions

Parkinson's Disease

Outcome Measures

Primary Outcomes (1)

  • Barratt Impulsiveness Scale

    up to three months

Study Arms (1)

PD patients

OTHER
Other: magnetic resonance imaging

Interventions

magnetic resonance imagingOTHER
PD patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Early onset PD patients and late onset PD patients with siblings available PD patients with or without impulse control disorders Current or past treatment with dopamine agonists or levodopa PD patients without dementia Age \< 80 ans

You may not qualify if:

  • Early onset PD patients and late onset PD patients without siblings available PD patients with dementia Age \> 80 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Pascal DERKINDEREN

Nantes, France

Location

Chu de Poitiers

Poitiers, 86021, France

Location

Marc VERIN

Rennes, France

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Jean-Luc HOUETO, MD PhD

    Poitiers University Hospital, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2015

First Posted

June 4, 2015

Study Start

November 21, 2014

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

October 5, 2021

Record last verified: 2021-09

Locations

FR(3)